To ensure the comprehensive inclusion of potential RCTs and minimise the subjective influence, two authors (M-YT and C-YM) will independently screen the literature. The data from each database will be imported into Endnote (V.X20, Clarivate, USA) to eliminate duplicate documents. The imported literature will then undergo a title and abstract screening to exclude non-compliant articles based on predetermined inclusion and exclusion criteria. The remaining papers will undergo a full-text assessment to determine eligibility. In case of any disagreements, the third author (QZ) will provide evaluation and facilitate consensus (online supplemental material 2 ).
Endnote v x20
Manufactured by Clarivate
Sourced in United States
EndNote v.X20 is a reference management software that allows users to collect, organize, and format citations and bibliographies. It provides a streamlined workflow for managing references and creating formatted citations within various document types.
Automatically generated - may contain errors
Lab products found in correlation
4 protocols using endnote v x20
1
Systematic Literature Screening Protocol
2
Systematic Review of RCTs in MEDLINE
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
In June 2022, an in-depth search was conducted in MEDLINE via PubMed for RCTs published between 1 January 2011 and 31 December 2021 in the journals included. The search was performed by two authors experienced in literature searching (MV and TC) and used the Cochrane Highly Sensitive Search Strategy for identifying randomised trials19 in MEDLINE adapted by removing terms referring to drug therapy and using a temporal filter (online supplemental file S1 ). To improve sensitivity, a second research was performed on the website of each journal via ‘Advanced Search Mode’ using the words ‘RCT’ in the title field.
Two authors (MV and TC) independently examined the bibliographic records identified by the search string to include the RCT studies. When the title or abstract was insufficient to determine eligibility, the full text was evaluated. Disagreements were resolved through discussion with a third author (MB) until consensus was reached. The identified abstracts were archived in EndNote V.X20 (Clarivate Analytics) and subsequently imported into an Excel data set. The double abstracts were removed with the appropriate function of the reference management software.
Two authors (MV and TC) independently examined the bibliographic records identified by the search string to include the RCT studies. When the title or abstract was insufficient to determine eligibility, the full text was evaluated. Disagreements were resolved through discussion with a third author (MB) until consensus was reached. The identified abstracts were archived in EndNote V.X20 (Clarivate Analytics) and subsequently imported into an Excel data set. The double abstracts were removed with the appropriate function of the reference management software.
3
Systematic Scoping Review Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Following the search, all identified citations will be collated and uploaded into EndNote v.X20 (Clarivate Analytics, PA, USA) and the duplicates as well as reviews, editorials, and opinion papers will be removed by two reviewers separately. Following a pilot search, titles and abstracts will then be screened by two independent reviewers for assessment against the eligibility criteria for the review. Once the duplicates are removed, two reviewers will independently screen the title and abstract of the remaining articles against the inclusion and exclusion criteria. The full texts of the studies that passed this stage will be retrieved and further independently reviewed by two independent reviewers based on the eligibility criteria.
The reviewers will then compare their results, and if any disagreements arise at any of the stages of the process, a third reviewer will be consulted. Studies that do not meet the inclusion criteria will be documented and reasons for exclusion will be provided in the scoping review. The results of the search and the study inclusion process will be reported in full in the final scoping review and presented in a PRISMA flow diagram [30 (link)].
The reviewers will then compare their results, and if any disagreements arise at any of the stages of the process, a third reviewer will be consulted. Studies that do not meet the inclusion criteria will be documented and reasons for exclusion will be provided in the scoping review. The results of the search and the study inclusion process will be reported in full in the final scoping review and presented in a PRISMA flow diagram [30 (link)].
4
Systematic Literature Review Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Following the search, all identified citations were collated and uploaded into EndNote v.X20 (Clarivate Analytics, PA, USA) and duplicates removed. The resulting articles were then imported into Covidence – Cochrane’s systematic review management software [41 ]. Duplicates were removed once importation was complete, and title and abstract screening was undertaken against the eligibility criteria. A sample of 25 articles were assessed by all reviewers to ensure reliability in the application of the inclusion and exclusion criteria. Team discussion was used to ensure consistent application. The Covidence software supports blind reviewing with two reviewers required at each screening phase. Potentially relevant sources were retrieved in full text and were assessed against the inclusion criteria by two independent reviewers. Conflicts were flagged within the software which allows the team to discuss those that have disagreements until a consensus was reached. Reasons for exclusion of studies at full text were recorded and reported in the scoping review. The Preferred Reporting Items of Systematic Reviews extension for scoping reviews (PRISMA-ScR) checklist was used to guide the reporting of the review [42 (link)] and all stages were documented using the PRISMA-ScR flow chart [42 (link)].
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!